In this webinar on using p16/Ki67 dual staining biomarkers in the triage of HPV-positive patients, experts from the United States and China share their experiences with these biomarkers in their routine clinical practices. As a gynaecological oncologist at UVA Health, Professor Leigh Cantrell emphasises that explaining the science behind HPV and its role in cervical […]
The Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN) recently held its bi-annual conference in Seoul, South Korea, with the theme “Empowering Women, Together against Cervical Cancer”. Despite having many tools that can prevent, screen for and treat cervical cancer, the conference opened with a powerful statement: “Every two minutes, a woman dies of
Advancing women’s health: key takeaways from AOGIN 2024 Read More »
Speaking at EUROGIN 2024, Prof Dietmar Schmidt, Consultant Pathologist at MVZ Histology, Cytology and Molecular Diagnostics, talks about the benefits of using p16/Ki67 dual staining biomarkers as a predictor of risk for HPV-positive patients. Now with routine vaccination programmes being implemented alongside HPV primary screening in many countries, experts are looking to optimise the triage
In this webinar on optimising triage of HPV-positive patients with the use of p16/Ki67 dual staining biomarkers, two experts from Singapore General Hospital share their experiences with the use of this triage method. Prof Tay Sun Kuie, Clinical Professor and Senior Consultant OB/GYN and Dr Sangeeta Mantoo, Senior Consultant at the Department of Anatomical Pathology,
Optimising triage of HPV-positive patients with p16/Ki67 dual staining biomarkers Read More »
As Vice President and Associate Chief Medical Officer at BioReference Laboratories, one of the largest clinical labs in the United States, Dr Tamera Paczos oversaw the addition of p16/Ki-67 dual staining assays to the lab’s assay portfolio. In the US, these assays are used in triage to further risk stratify women who have come for
Implementing p16/ki67 dual stain at a large US commercial lab: Dr Tamera Paczos Read More »
While cervical cancer is preventable, an estimated 14,000 new cases are diagnosed in the United States every year, leading to almost 4,300 deaths from the disease. As Professor Emeritus of Pathology and Clinical Gynaecology at the University of Virginia Health System, Prof Mark Stoler is working towards preventing these deaths. In this talk at the
Prof Mark Stoler on HPV primary screening with biomarker based triage Read More »
Dr Sharad Paul is a New Zealand-based skin cancer specialist, social entrepreneur, and author. In this Q&A with Chitra Nair, APAC Pathology Lead at Roche Diagnostics Asia Pacific, he shares his thoughts on key issues in skin health management and what they mean for the practice of laboratory medicine, drawing upon his vast clinical experience,
Dr Sharad Paul on skin health, cancer, and the evolving role of pathology Read More »
Compared to traditional immunohistochemistry (IHC) and protein staining techniques, many pathologists prefer bright-field chromogenic or silver-enhanced in situ hybridization (ISH) staining more than fluorescence ISH, because it provides more stable results that can be reviewed over time without fears of degradation. In a recent webinar hosted by Roche Diagnostics Asia Pacific, two Australian pathologists discussed
HER2 DISH assay showcases value of image analysis algorithms Read More »
Of the many specialty areas for which clinical labs are implementing digital pathology, breast cancer is among the most common — and one of the applications where digital pathology has been the most helpful. The ability to perform whole-slide imaging has been valuable for samples with highly heterogeneous tissue and in light of the increasing
For breast cancer analysis, digital pathology offers a streamlined approach Read More »
In 2019, Dr Thomas Grogan published Chasing the Invisible, a memoir about his experience in launching, scaling and selling Ventana Medical Systems, a pioneer and leading provider of automated instruments for tissue diagnosis. In the third instalment of this three-part series on Dr Grogan’s life and career, we explore some of the key lessons from
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox.
